Patrick Magrath1,2, Nyasha Maforo2,3, Mike Loecher4, Grace Kim5, Holden H. Wu 1,2,3, Ashley Prosper2, Pierangelo Renella2, Nancy Halnon6, and Daniel B. Ennis 4
1Bioengineering, University of California, Los Angeles, CA, United States, 2Radiology, University of California, Los Angeles, CA, United States, 3Physics and Biology in Medicine IDP, University of California, Los Angeles, CA, United States, 4Radiology, Stanford University, Stanford, CA, United States, 5Biostatistics, University of California, Los Angeles, CA, United States, 6Pediatrics, University of California, Los Angeles, CA, United States
Synopsis
Duchenne Muscular Dystrophy is a common fatal inherited genetic disorder
impacting 1:3800 male births, and cardiac failure is the primary source of mortality in this cohort. Decreases in LVEF measured by CINE and fibrosis measured by LGE are late and highly variable outcomes. Herein we demonstrate that peak systolic circumferential strain (Ecc) and Twist measured by MR Tagging provide evidence of earlier changes in cardiac function in a substantial DMD cohort, holding promising applications for patient treatment and the evaluation of novel therapeutics.
Introduction
Duchenne
Muscular Dystrophy (DMD) is the most common fatal genetic disorder, impacting
1:3,800 male births and ultimately leading to respiratory or cardiac failure
during late adolescence [1-2]. The progression of cardiac
disease is highly variable in DMD [3-4], and while
decreases in left ventricular ejection fraction (LVEF) and presence of cardiac
fibrosis as measured by Late Gadolinium Enhancement Positivity (LGE+) from MRI
have proven useful, these changes occur late in the disease process and are highly variable [5-8].
Earlier biomarkers of cardiac dysfunction are
vital for treatment planning and the evaluation of novel therapeutics. Peak systolic
mid-wall LV circumferential strain (Ecc) derived from MRI tagging has
been reported to effectively distinguish DMD patients from normal volunteers
despite no significant differences in LVEF [8-10]. Peak LV twist, torsion,
and circumferential-longitudinal shear angle (θ_CL) (Figure 1) measured from MR Tagging may also be earlier
biomarkers of cardiac dysfunction in this cohort [11-12].
The objectives of this study were: 1)
to characterize a spectrum of functional and rotational LV biomarkers in a cohort
of boys with DMD in comparison to normal age-matched controls; and 2) to identify
LV biomarkers that detect the onset of cardiomyopathy in the absence of abnormal
LVEF or LGE+.Methods
Study Population – with IRB approval, pediatric patients with DMD (N=43, all
male, age=13.8±3.8 years) and age-matched healthy volunteers with no history of cardiac
disease (N=16, all male, age=13.6±2.9 years). Table 1.
MRI Protocol – 1.5T or 3T
(Siemens Avanto or Skyra). The exam included: A) breath-held basal, mid-ventricular, and apical LV
short-axis grid tagged MRI (resolution = 1.4x1.4x8mm, TE/TRes=2.12/24-48 ms, 11-31 phases, tag
spacing=8mm), B) post-contrast
CINE imaging with either breath held (N=17) cine bSSFP (matrix = 256x156, resolution
= 1.4x1.4 mm, TE/TRes=1.2/28.1-45.1
FA = 40-54º, BW = 800-1300) or free-breathing cine
bSSFP [13] (N=26, matrix =
192x120, resolution = 1.4x1.4, TE/TRes=1.2/45.1-64.4
ms, FA = 40º, BW = 930). Healthy
volunteers (N = 16) were imaged with an identical free-breathing protocol
without contrast, and C) Post contrast conventional
breath-held LGE (N=17, resolution: 1.4x1.4x6.0 mm TE/TRes: 2.01/750 ms) or free breathing LGE Imaging (N=26, spatial resolution:
1.4x1.4x8.0mm, TE/TRes: 1.19/904 ms, averages = 8) [14]
Image Analysis - CINE and LGE images
were analyzed by clinicians (PR or AP) using commercial software (Circle CVI42,
Circle Cardiovascular Imaging Inc.) or Medis (Medis Cardiovascular Imaging). Peak
LV mid-wall Lagrangian circumferential strain (Ecc) at the mid-ventricular
level and LV basal and apical angular rotation were estimated from
tagged MRI (Diagnosoft, Myocardial Solutions). Peak LV twist, torsion, and CL-shear angle (θ_CL) were defined as shown in Figure 1 [15].
Statistical
Analysis - Normally distributed data were compared with a
two-tailed t-test and a Box-Cox transformation accounted for non-normal data. Holm-Sidak
post hoc correction accounted for multiple comparisons. A sub-analysis
stratified patients into “LGE(-) DMD” (no scar present) and “LGE(+) DMD” groups.
Multiple-regression
analysis was used to test for relationships between LVEF and peak mid-wall LV Ecc, twist, torsion, and θ_CL. Significant correlations were defined as a p-value <0.05
compared to the null hypothesis that the data was best correlated with a
constant term.
A
binomial logistic regression model tested the ability of each measured
biomarker to distinguish: 1) healthy volunteers from a DMD population; 2) healthy
volunteers from LGE(-) DMD patients; and 3) LGE(-) DMD patients from LGE(+) DMD
patients. Results were displayed as receiver-operator curves (ROC), and the area
under the curve (AUC) was reported to demonstrate the predictive ability of
each biomarker.Results
There was a significant difference between patients with DMD and volunteers in
LVEF (51.1±9.7% vs. 57.7±4.0%, p<0.01), peak mid-wall Ecc (-15.9±4.5% vs.
-19.5±1.9%, p<3.9x10-4), peak LV twist (9.0±4.7° vs. 15.6±3.1°, p<1.1x10-4), peak LV torsion (1.7±0.9°/mm vs. 2.8±0.50°/mm, p<1.1x10-4), and peak LV θ_CL (5.2±2.5° vs. 7.04±3.5°, p<2.1x10-3).
Table 2 shows a
sub-analysis of these results separated into healthy volunteers, LGE(-) DMD and
LGE(+) DMD groups. There was a statistically significant reduction in peak
mid-wall Ecc and peak LV torsion between healthy volunteers
and LGE negative patients with DMD, but no corresponding significant difference
in LVEF. Furthermore, in
DMD patients without fibrosis ( LGE(-) ), LVEF was not substantially
reduced outside a standard “normal” threshold of < 55%.
Notably, there was a further significant and progressive reduction in
all cardiac MRI biomarkers between LGE(-) and LGE(+) patients with DMD.Discussion/Conclusion
Patients with DMD exhibit
decreases in peak LV Twist, Torsion, θ_CL, and Ecc that
precede decreases in LVEF or the presence of scar as measured by LGE. While all
cardiac MRI biomarkers (including LVEF) were effective at distinguishing
between the DMD and age-matched healthy population and between LGE(+) and LGE(-) DMD, only peak LV twist, torsion, and Ecc
significantly distinguished between the healthy volunteers and the LGE(-) DMD
population.
Differentiating LGE(-) DMD patients from a
population of age-matched healthy volunteers provides important evidence that
these cardiac MRI biomarkers highlight early signs of cardiac dysfunction.
Both peak LV Twist and Ecc are linked to underlying cardiomyocyte performance, an early “snapshot”
of the transition between normal cardiac performance and later DMD cardiomyopathy as measured by LGE(+) and reduced LVEF. This
early information is vital in the evaluation of novel therapeutics and in the
early treatment of cardiac symptoms in DMD.
Acknowledgements
NIH R01 HL131823 to DBEReferences
1. McNally
EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D, Finder JD, Groh WJ,
Hoffman EP and Judge DP. Contemporary cardiac issues in Duchenne muscular
dystrophy. Circulation.
2015;131:1590-1598.
2. Weingärtner
S, Roujol S, Akçakaya M, Basha TA and Nezafat R. Free‐breathing
multislice native myocardial T1 mapping using the slice‐interleaved T1
(STONE) sequence. Magnetic resonance in
medicine. 2015;74:115-124.
3. Bushby
K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald
C and Pandya S. Diagnosis and management of Duchenne muscular dystrophy, part
2: implementation of multidisciplinary care. The Lancet Neurology. 2010;9:177-189.
4. Bushby
K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald
C and Pandya S. Diagnosis and management of Duchenne muscular dystrophy, part
1: diagnosis, and pharmacological and psychosocial management. The Lancet Neurology. 2010;9:77-93.
5. Tandon
A, Villa CR, Hor KN, Jefferies JL, Gao Z, Towbin JA, Wong BL, Mazur W, Fleck RJ
and Sticka JJ. Myocardial fibrosis burden predicts left ventricular ejection
fraction and is associated with age and steroid treatment duration in Duchenne
muscular dystrophy. Journal of the
American Heart Association. 2015;4:e001338.
6. Silva
MC, Meira ZMA, Giannetti JG, da Silva MM, Campos AFO, de Melo Barbosa M,
Starling Filho GM, de Aguiar Ferreira R, Zatz M and Rochitte CE. Myocardial
delayed enhancement by magnetic resonance imaging in patients with muscular
dystrophy. Journal of the American
College of Cardiology. 2007;49:1874-1879.
7. Puchalski
MD, Williams RV, Askovich B, Sower CT, Hor KH, Su JT, Pack N, Dibella E and
Gottliebson WM. Late gadolinium enhancement: precursor to cardiomyopathy in
Duchenne muscular dystrophy? The international
journal of cardiovascular imaging. 2009;25:57-63.
8. Hor
KN, Wansapura J, Markham LW, Mazur W, Cripe LH, Fleck R, Benson DW and
Gottliebson WM. Circumferential strain analysis identifies strata of
cardiomyopathy in Duchenne muscular dystrophy. Journal of the American College of Cardiology. 2009;53:1204-1210.
9. Ashford
M, Liu W, Lin S, Abraszewski P, Caruthers S, Connolly A, Yu X and Wickline SA.
Occult cardiac contractile dysfunction in dystrophin-deficient children
revealed by cardiac magnetic resonance strain imaging. Circulation. 2005;112:2462-2467.
10. Hagenbuch
SC, Gottliebson WM, Wansapura J, Mazur W, Fleck R, Benson DW and Hor KN.
Detection of progressive cardiac dysfunction by serial evaluation of
circumferential strain in patients with Duchenne muscular dystrophy. The American journal of cardiology.
2010;105:1451-1455.
11. Reyhan
ML, Wang Z, Kim HJ, Halnon NJ, Finn JP and Ennis DB. Effect of free‐breathing on
left ventricular rotational mechanics in healthy subjects and patients with
duchenne muscular dystrophy. Magnetic
resonance in medicine. 2017;77:864-869.
12. Reyhan
M, Wang Z, Li M, Kim HJ, Gupta H, Lloyd SG, Dell'Italia LJ, Denney T and Ennis
DB. Left ventricular twist and shear in patients with primary mitral
regurgitation. Journal of Magnetic
Resonance Imaging. 2015;42:400-406.
13. Kellman
P, Chefd'hotel C, Lorenz CH, Mancini C, Arai AE and McVeigh ER. Fully
automatic, retrospective enhancement of real‐time acquired cardiac
cine MR images using image‐based navigators and respiratory motion‐corrected
averaging. Magnetic resonance in medicine.
2008;59:771-778.
14. Kellman
P, Larson AC, Hsu LY, Chung YC, Simonetti OP, McVeigh ER and Arai AE. Motion‐corrected free‐breathing
delayed enhancement imaging of myocardial infarction. Magnetic resonance in medicine. 2005;53:194-200.
15. Young AA
and Cowan BR. Evaluation of left ventricular torsion by cardiovascular magnetic
resonance. Journal of Cardiovascular
magnetic resonance. 2012;14:49.